Vitamin B3 Market Size, Share & Industry Analysis, By Source (Synthetic and Natural), By Grade (Feed Grade and Nutrition Grade), By Form (Dry and Liquid), By Application (Animal Feed, Food & Beverages, Dietary Supplements, Pharmaceuticals, Cosmetics, and Others), and Regional Forecast, 2026–2034

The global vitamin B3 market size was valued at USD 676.08 million in 2025. The market is projected to grow from USD 719.09 million in 2026 to USD 1,203.28 million by 2034, exhibiting a CAGR of 6.65% during the forecast period.

Vitamin B3 is an essential water-soluble vitamin critical for energy metabolism, cardiovascular health, neurological function, skin health, and lipid regulation. It is widely incorporated into dietary supplements, pharmaceutical formulations, functional foods, animal nutrition, and personal care products. The market is further driven by mandatory food fortification programs, regulatory approvals for therapeutic niacin use, and increasing clinical research validating niacin’s role in lipid control and cellular energy production. Asia Pacific remains the largest production hub, while North America and Europe represent high-value consumption markets, driven by dietary supplements and pharmaceutical demand.

The global vitamin B3 industry is moderately consolidated, with major players including Lonza Group, DSM-Firmenich, BASF SE, Jubilant Pharmova Limited, and Vanetta Food Ingredients, among others.

Vitamin B3 Market Trends

Rising Consumption of Vitamin B-Complex and Energy Supplements to Drive Market Growth

Consumption of vitamin B-complex supplements, particularly those containing Vitamin B3, has increased significantly over the past decade. Niacin plays a central role in NAD/NADP synthesis, which is essential for cellular energy production. Vitamin B3 is increasingly used in Vitamin B3 supplements targeting fatigue reduction, metabolic health, cognitive performance, and cardiovascular wellness. In developing regions, niacin remains a critical nutrient for preventing pellagra and micronutrient deficiencies, thereby reinforcing sustained baseline demand. This trend is expected to continue, offering strong global vitamin B3 market growth opportunities.

• According to global nutrition and public health data, over 30–40% of adults in developed economies regularly consume vitamin supplements, with B-complex nutritional products ranking among the top-selling categories.

Download Free sample to learn more about this report.

MARKET DYNAMICS

Market Drivers

Growing Demand for Preventive Healthcare and Nutritional Fortification Supporting Market Expansion

Vitamin B3 (niacin) plays a crucial role in government-led food fortification programs aimed at combating micronutrient deficiencies globally. These programs target staple foods, including wheat flour, maize flour, cereals, and infant products, to ensure broader nutritional access, particularly among vulnerable populations. In Asia Pacific markets, such as India, the fortification of wheat flour, rice, and cereals addresses malnutrition through the mandatory addition of micronutrients. Programs emphasize cost-effective strategies, with minimal price increases for consumers.

• According to the data from the Food Fortification Initiative (FFI), in November 2023, approximately 93 countries mandate the fortification of at least one industrially milled cereal grain (wheat or maize flour).

Market Restraints

Adverse Effects and Regulatory Dosage Limitations to Restrict Market Growth

High-dose niacin use commonly triggers flushing due to the increased prostaglandin-mediated vasodilation, alongside risks of hepatotoxicity and gastrointestinal issues such as nausea and discomfort. These adverse effects have led regulatory bodies worldwide to enforce dosage caps and labeling requirements for supplements. Such restrictions hinder broader market adoption, particularly in OTC formulations.

• According to the U.S. Dietary Reference Intake (DRI) guidelines published by the National Academies and adopted by U.S. nutrition policy, the Tolerable Upper Intake Level (UL) for niacin in adults is capped at 35 mg/day. This threshold was specifically established to prevent adverse effects, with flushing identified as the critical effect used to set this limit.

Market Opportunities

Expanding Use of Vitamin B3 in Cosmetics and Dermatological Applications to Unlock New Growth

Vitamin B3 (niacinamide) has gained significant traction in the global personal care and cosmetics industry due to its anti-inflammatory, skin-repairing, brightening, and anti-aging properties. Niacinamide is now one of the top five most widely used active ingredients in skincare formulations globally. The rapid growth of clean-label beauty, cosmeceuticals, and dermatologically tested skincare products is creating new revenue streams for Vitamin B3 manufacturers, particularly in Europe, North America, Japan, and South Korea.

• According to safety evaluations issued by the European Commission’s Scientific Committee on Consumer Safety (SCCS), niacinamide is classified as safe for use in cosmetic products at concentrations of up to 10% in leave-on formulations and up to 5% in rinse-off products, positioning it among a limited group of multifunctional cosmetic actives approved at relatively high usage levels. This regulatory clearance has significantly accelerated adoption across dermatologically tested skincare, anti-aging products, and barrier-repair formulations in Europe, which hosts the world’s largest regulated cosmetics market.

SEGMENTATION ANALYSIS

By Source

Synthetic Segment Dominated Market Due to Cost Efficiency and Industrial Scalability

On the basis of source, the global market is segmented into synthetic and natural.

The synthetic segment led the market, valued at USD 560.65 million in 2025, accounting for the largest global vitamin B3 market share due to its consistent purity, cost-effectiveness, large-scale manufacturability, and wide regulatory acceptance. Synthetic niacinamide is widely used in animal feed premixes, fortified foods, pharmaceuticals, and cosmetics, where formulation stability and volume consistency are crucial. Its dominance is further reinforced by strong demand from emerging economies with large feed and food fortification programs.

The natural segment is projected to grow at the fastest CAGR of 7.90% from 2026 to 2034, driven by rising demand for clean-label preferences, the growing use of naturally derived niacinamide in premium skincare, nutraceuticals, and plant-based supplements, and increasing consumer preferences to pay for bio-based ingredients.

To know how our report can help streamline your business, Speak to Analyst

By Grade

Nutrition Grade Segment Held Major Share Driven by Expanding Therapeutic and Dermatological Applications

Based on grade, the market is segmented into feed grade and nutrition grade.

The nutrition grade segment dominated the global market, valued at USD 413.54 million in 2025, accounting for the largest market share due to its extensive use in cholesterol-lowering therapies, dermatological treatments, clinical nutrition, and prescription as well as OTC formulations. The segment benefits from stringent quality standards, high purity requirements, and growing demand for niacinamide in skin barrier repair, anti-inflammatory treatments, and preventive healthcare applications, particularly across North America and Europe.

The feed grade segment is expected to grow at a steady pace, expanding at a CAGR of 5.98% from 2026 to 2034, driven by increasing healthcare expenditures, the rising incidence of lifestyle-related disorders, and the rapid adoption of niacinamide in advanced skincare and therapeutic formulations.

By Form

Dry Segment Led Market Due to Superior Stability and Broad Applicability

On the basis of form, the global market is segmented into dry and liquid.

The dry segment held the dominant market position, valued at USD 498.95 million in 2025, owing to its longer shelf life, ease of handling, superior stability, and widespread use in animal feed blends, tablets, capsules, powdered supplements, and fortified food products. Dry niacinamide remains the preferred form for bulk transportation and industrial-scale formulation.

The liquid segment is projected to grow at the fastest CAGR of 7.74% from 2026 to 2034, supported by the increasing adoption of functional beverages, liquid dietary supplements, injectable pharmaceuticals, and cosmetic serums, where rapid absorption and formulation flexibility are required.

By Application

Dietary Supplements Segment Dominated Due to Rising Consumer Focus on Preventive Healthcare

Based on application, the global market is segmented into animal feed, food & beverages, dietary supplements, pharmaceuticals, cosmetics, and others.

The dietary supplements segment dominated the market, valued at USD 164.92 million in 2025, accounting for the largest share of the global market. Dominance is driven by the widespread use of niacinamide in daily nutrition supplements, multivitamin formulations, metabolic health products, and skin health supplements, supported by rising consumer focus on preventive healthcare, immunity support, and lifestyle disease management. This segment is also projected to register the fastest growth, expanding at a CAGR of 7.75% during 2026–2034, fueled by increasing supplement consumption across North America, Europe, and Asia Pacific, along with strong growth in e-commerce and direct-to-consumer nutrition platforms.

The food & beverages segment is expected to witness steady growth over the forecast period, supported by the ongoing use of vitamin B3 in food fortification programs, functional beverages, cereals, bakery products, and dairy formulations. Growth in this segment remains moderate due to its mature penetration and regulatory dosage limits. Still, it continues to benefit from public health initiatives addressing micronutrient deficiencies and sustained demand for vitamin B3 fortified staple foods.

Vitamin B3 Market Regional Outlook

Regionally, the report covers the global market analysis across North America, Europe, Asia Pacific, South America, and the Middle East & Africa.

Asia Pacific

To get more information on the regional analysis of this market, Download Free sample

Asia Pacific dominated the global market, valued at USD 276.07 million in 2025, accounting for 40.83% of the global market share. Asia Pacific represents the fastest-growing regional market for Vitamin B3, driven by large population size, rising nutritional awareness, expanding pharmaceutical manufacturing capacity, and rapid growth in functional foods and cosmetics. The region is also a global production hub for Vitamin B3, supported by cost-efficient manufacturing and strong export activity. Cultural emphasis on preventive healthcare and beauty-from-within concepts further accelerates demand.

China Vitamin B3 Market

China represented the largest market globally, valued at approximately USD 126.23 million in 2025. China represents the largest market in the Asia Pacific, supported by large-scale vitamin production, extensive use in animal nutrition and fortified foods, and growing domestic consumption of dietary supplements. The country’s rapidly expanding skincare and personal care industry has also significantly increased demand for cosmetic-grade niacinamide.

India Vitamin B3 Market

India’s market was valued at around USD 52.96 million in 2025, driven by nutraceutical exports, pharmaceutical formulation expansion, and increasing adoption of preventive nutrition among urban consumers. Government initiatives addressing micronutrient deficiencies and growing demand for affordable supplements support steady Vitamin B3 consumption.

Europe

Europe accounted for USD 145.00 million in 2025, representing 21.45% of the global market value, and is projected to grow at a CAGR of 6.87%. Europe represents one of the most regulation-driven Vitamin B3 markets, accounting for a significant share of global value consumption. Market growth is supported by mandatory enrichment of cereal-based foods, strong penetration of dietary supplements, and expanding use of niacinamide in cosmeceuticals and dermatological formulations.

Germany Vitamin B3 Market

Germany leads Europe and was valued at USD 33.12 million in 2025, driven by its robust pharmaceutical manufacturing ecosystem, advanced nutraceutical sector, and strong consumer trust in preventive healthcare products. Vitamin B3 is widely used in B-complex supplements, clinical nutrition products, and prescription lipid-modifying therapies, while Germany’s position as a hub for premium skincare and dermo-cosmetic brands further supports niacinamide demand.

U.K. Vitamin B3 Market

The U.K. market was valued at approximately USD 27.62 million in 2025, driven by high dietary supplement consumption, the expansion of functional food categories, and strong growth in online health and wellness retail channels. The rising consumer focus on energy metabolism, cardiovascular health, and skin barrier repair has increased the use of Vitamin B3 in supplements and personal care products.

North America

North America was valued at USD 181.93 million in 2025, accounting for 26.91% of the global market share, and is projected to register the fastest regional CAGR of 7.34% from 2026 to 2034. North America is a high-value, innovation-driven market for Vitamin B3, characterized by widespread dietary supplement usage, established food fortification mandates, and advanced pharmaceutical applications. The region benefits from strong consumer awareness regarding micronutrient intake and preventive health benefits, alongside significant demand from the cosmetics and dermatology industries, where niacinamide is a preferred active ingredient due to its safety and multifunctionality.

U.S. Vitamin B3 Market

The U.S. accounted for 78.52% of regional demand, valued at approximately USD 142.85 million in 2025, supported by long-standing grain enrichment programs, high per-capita supplement consumption, and strong pharmaceutical utilization of niacin in the management of dyslipidemia. The U.S. also represents a major growth center for niacinamide-based skincare, driven by dermatologist recommendations and clean-label beauty trends.

South America and Middle East & Africa

South America and the Middle East & Africa represent emerging markets for Vitamin B3, with growth supported by food fortification initiatives, improving healthcare access, and rising awareness of nutritional deficiencies. Demand in these regions is primarily concentrated in basic supplements, fortified staple foods, and animal nutrition, with gradual expansion into personal care applications. South America represented USD 46.49 million in 2025, accounting for 6.88% of the global share, and is projected to grow at a CAGR of 5.85%.

UAE Vitamin B3 Market

The UAE market was valued at approximately USD 4.68 million in 2025. The UAE serves as a regional hub for premium dietary supplements and imported personal care products, with demand for Vitamin B3 supported by high consumer spending power, expatriate-driven wellness consumption, and regulated supplement retail channels.

COMPETITIVE LANDSCAPE

Key Industry Players

Key Players are Adopting Innovative Product Packaging Designs to Attract New Consumers and Increase Product Sales

Major companies operating in the market include Lonza Group, BASF SE, DSM-Firmenich, Jubilant Pharmova Limited, and Vanetta Food Ingredients. Players are investing in high-purity pharmaceutical and cosmetic-grade Vitamin B3, capacity expansion, and strategic partnerships with supplement and skincare brands.

Key Players in the Vitamin B3 Market

List of Key Vitamin B3 Companies Profiled

• BASF SE (Germany)
• DSM-Firmenich (Netherlands)
• Lonza Group (Switzerland)
• Jubilant Pharmova Limited (India)
• Vanetta Food Ingredients (U.S.)
• Zhejiang NHU Co., Ltd. (China)
• Brother Enterprises Holding Co., Ltd. (China)
• Shandong Hongda Bio-Tech Co., Ltd. (China)
• Vertellus Holdings LLC (U.S.)
• Anhui Redpont Biotechnology Co., Ltd. (China)

KEY INDUSTRY DEVELOPMENTS

• August 2025: Bruhin Muller, a luxury skincare brand from Geneva, Switzerland, launched its B3 NAD+ Collection. The lineup features advanced serums and crèmes using Vitamin B3, NAD+, NMN, and peptides to target cellular rejuvenation and anti-aging.

• January 2025: Jubilant Ingrevia commissioned a new cGMP-compliant facility at Bharuch, Gujarat, dedicated to producing Niacinamide (Vitamin B3) for global clients. The plant offers a 5,000 metric tonne annual capacity and focuses on nutraceuticals, dietary-active ingredients, and food-grade Niacinamide suitable for human consumption. It extends the company's existing USFDA-approved operations, already serving markets in the US, Europe, Japan, and beyond.
• June 2024: Nectar Beautyhub, a leading beauty and skincare retailer primarily based in Nigeria, announced the unveiling of Tiam B3 Niacin Sunscreen, a groundbreaking product that combines sun protection with skin-brightening benefits.
• February 2024: Dove launched its VitaminCare+ Deodorant, an aluminum-free formula superpowered with Vitamin B3 (niacinamide), to provide 72-hour odor control while nourishing underarm skin. The product enhances the skin's natural antimicrobial peptides (AMPs) to fight odor-causing bacteria and repairs the moisture barrier up to 10 layers deep, reducing dryness and improving tone over time.
• August 2022: Bernier Pharmaceuticals, a pharmaceutical brand, launched a new product, SolarCareB3, a high-dose vitamin B3 tablet.

REPORT COVERAGE

The global Vitamin B3 market industry report provides in-depth analysis of the market, highlighting key aspects such as global market trends, supply chain, market dynamics, prominent companies, research and development investments, and end-use applications. Additionally, the research report offers insights into global market analysis and highlights key industry developments.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation